Bibliographic Citation
| - Bidard F-C, Autret A., Petit T., André F., Dalenc F., Lévy C., Ferrero J-M, Romieu G., Bonneterre J., Lerebours F., Bachelot Thomas, Kerbrat P., Campone M., Eymard J-C, Mouret-Reynier M-A, Gligorov J., Hardy-Bessard A-C, Lortholary A., Soulie P., Boher J-M, Proudhon C., Charafe-Jaufret E., Lemonnier J., Bertucci F., Viens P.. Circulating Tumour Cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab. Annals of Oncology, Elsevier, 2017, 28, pp.mdw535. ⟨10.1093/annonc/mdw535⟩
- Bidard François-Clément, Autret A., Petit Tillys, André Frédéric, Dalenc F., Lévy C., Ferrero J-M, Romieu G., Bonneterre J., Lerebours F., Bachelot Thomas, Kerbrat P., Campone M., Eymard J-C, Mouret-Reynier Marie-Ange, Gligorov Joseph, Hardy-Bessard A-C, Lortholary Alain, Soulie P., Boher J-M, Proudhon Charlotte, Charafe-Jaufret E., Lemonnier J., Bertucci François, Viens P.. Circulating Tumour Cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab. Annals of Oncology, 2017, 28, pp.mdw535. ⟨10.1093/annonc/mdw535⟩
|